Compare COGT & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COGT | LW |
|---|---|---|
| Founded | 2014 | 1950 |
| Country | United States | United States |
| Employees | N/A | 10100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.0B |
| IPO Year | 2018 | 2016 |
| Metric | COGT | LW |
|---|---|---|
| Price | $37.08 | $46.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 7 |
| Target Price | $33.50 | ★ $56.14 |
| AVG Volume (30 Days) | 1.4M | ★ 1.6M |
| Earning Date | 05-22-2026 | 03-19-2026 |
| Dividend Yield | N/A | ★ 3.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.90 |
| Revenue | ★ $7,871,000.00 | N/A |
| Revenue This Year | N/A | $4.23 |
| Revenue Next Year | $1,180.55 | N/A |
| P/E Ratio | ★ N/A | $50.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.72 | $39.79 |
| 52 Week High | $43.73 | $67.07 |
| Indicator | COGT | LW |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 44.36 |
| Support Level | $36.52 | $41.41 |
| Resistance Level | $41.02 | $57.57 |
| Average True Range (ATR) | 1.86 | 1.45 |
| MACD | -0.15 | -0.34 |
| Stochastic Oscillator | 30.69 | 24.55 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.